Hilleman Laboratories’ thermostability technology to help improve coverage of Routine Immunisation… Apr 30, 2014 Quarter of the current birth cohort of 27 million babies in India unimmunised
Brazilian National Sanitary Surveillance Agency certifies Next Breath Apr 30, 2014 Next Breath is now authorised to conduct Pharmaceutical Equivalence studies for Brazil
Johnson & Johnson announces new collaboration to enhance access to anti-TB compound Apr 30, 2014 Will expand reach to more than 130 low and middle-income countries outside of US Johnson & Johnson announced that its…
US FDA approves Zykadia for late-stage lung cancer Apr 30, 2014 Breakthrough therapy drug approved four months ahead of review completion goal date
Glenmark’s novel monoclonal antibody GBR 900 enters human trials Apr 29, 2014 GBR 900 is a first in class monoclonal antibody for the treatment of chronic pain targeting TrkA, the receptor of NGF
“Full immunisation is the birthright of every child” Apr 29, 2014 Disease is an event, but prevented disease is a non-event. National Immunisation Week (April 24 to 30) is the appropriate time to…
Mylan challenges FDA ruling on Celecoxib exclusivity Apr 28, 2014 Believes that the FDA has seriously erred in its decision in this case Mylan Inc. (Nasdaq: MYL) announced that it has filed suit…
Bilcare receives National Intellectual Property Award 2014 by GoI Apr 28, 2014 Developed path-breaking technology solution - nonClonableID technology with over 200 patent applications and 36 granted patents…
FDA approves first human papillomavirus test for primary cervical cancer screening Apr 28, 2014 The cobas HPV test is manufactured by Roche Molecular Systems
Jubilant Life Sciences receives ANDA approval Apr 28, 2014 Spironolactone is the generic version of Aldactone®(of GD Searle) Jubilant Life Sciences Ltd, an integrated Pharmaceuticals and…
Novartis granted injunctions against four other generic makers over Galvus Apr 28, 2014 Novartis filed an RTI with the DCGIseeking information regarding regulatory approvals issued for Vildagliptin
Lonza appoints Marc Funk as COO of the Pharma & Biotech segment Apr 28, 2014 Funk has been the Group’s Chief Legal Officer and Board Secretary since 2009
Oviya MedSafe partners with Assured Information Systems Apr 25, 2014 Strategic alliance offers cost-effective regulatory-compliant global pharmacovigilance support
Quintiles and Biogen Idec in partnership Apr 25, 2014 The five-year collaboration is designed to leverage the expertise and experience from both organisations to optimise Biogen Idec’s…
Strides Arcolab receives USFDA nod for oral dosage facility Apr 25, 2014 Last USFDA inspection and approval for this facility in 2011 Strides Arcolab's Oral Dosage Forms manufacturing site (KRS…
Dr Arun Chandavarkar appointed as CEO and Joint Managing Director of Biocon Apr 25, 2014 Has been the Chief Operating Officer of Biocon since 2006
Dr Arun Chandavarkar Appointed as CEO and Joint Managing Director of Biocon Ltd Apr 25, 2014 Has been the Chief Operating Officer of Biocon since 2006 Biocon Ltd, Asia's premier biotechnology company, announced that the…
Genpact to Acquire Leading Regulatory Affairs Company in Life Sciences Apr 24, 2014 Enhances Domain Expertise and Operational Capabilities in Life Sciences Genpact Ltd. (NYSE: G), a global leader in transforming…
Emerging technologies redefine infectious disease diagnostics:F&S Apr 24, 2014 Diagnostics research for infectious diseases recieve little funding The diagnostics market for infectious diseases such as…